CAS: 1266227-69-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | T-3256336-d3 REF: TR-T002502CAS: 1266227-69-3 | - - - | 48,635.00 € | Fri 03 Jan 25 |
| T-3256336 REF: TR-T002500CAS: 1266227-69-3 | - - - | 51,850.00 € | Fri 03 Jan 25 |
 | T-3256336 REF: TM-T26246CAS: 1266227-69-3 | 98% | 1,000.00 €~2,617.00 € | Mon 13 Jan 25 |
T-3256336-d3
Controlled ProductCAS:1266227-69-3
Formula:
C31D3H42F2N5O5
Color and Shape:
Neat
Molecular weight:
608.735
Ref: TR-T002502
| 25mg | 48,635.00 € |
Estimated delivery in United States, on Friday 3 Jan 2025
T-3256336
Controlled ProductCAS:1266227-69-3
Applications T-3256336 is a selective antagonist of inhibitor of apoptosis protein (IAP) and apoptosis protein-1 …
Formula:
C31H45F2N5O5
Color and Shape:
Neat
Molecular weight:
605.72
Ref: TR-T002500
| 25mg | 51,850.00 € |
Estimated delivery in United States, on Friday 3 Jan 2025
T-3256336
CAS:1266227-69-3
T-3256336 is an oral IAP blocker targeting cIAP-1, cIAP-2, and XIAP.
Formula:
C31H45F2N5O5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
605.72
Ref: TM-T26246
| 25mg | 1,549.00 € | ||
| 50mg | 2,038.00 € | ||
| 100mg | 2,617.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
